Sunday, April 13 | 1:45–2:45 p.m.
Annette Leon, Ph.D., Hematogenix Laboratories
The growing impact of artificial intelligence (AI) on molecular diagnostics is undeniable. AI-powered tools are revolutionizing disease diagnosis at the molecular level, offering faster, more accurate, and cost-effective solutions that push the boundaries of what's possible in precision medicine. However, this innovation also brings significant concerns. Issues such as algorithmic bias and the ethical implications of AI-driven decisions are among the key challenges facing the future of AI in healthcare. In this presentation, we'll examine the current state of AI in molecular diagnostics and the critical questions surrounding its use.
Somak Roy, M.D., Cincinnati Children's Hospital Medical Center
Description to come.
The program includes sessions, networking opportunities, industry spotlights and more.
View program
